{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-030088","form_type":"8-K","ticker":"GNPX","cik":"0001595248","company_name":"Genprex, Inc.","filed_at":"2024-09-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.699465+00:00","generated_at":"2026-05-31T01:33:32.420982+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Genprex receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period","bullets":["Nasdaq letter dated Sept 26, 2024; stock fails minimum $1.00 bid price for 30 consecutive business days.","Cure period ends March 25, 2025; must have $1.00 closing bid for 10 consecutive days to regain compliance.","Company may qualify for additional 180-day period if it meets other listing standards and notifies Nasdaq.","Potential actions include reverse stock split; delisting risk if unable to cure.","Common stock continues trading on Nasdaq Capital Market while Company monitors bid price."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-030088","json":"https://secwatch.observer/filing/0001437749-24-030088.json","markdown":"https://secwatch.observer/filing/0001437749-24-030088.md","text":"https://secwatch.observer/filing/0001437749-24-030088.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595248/000143774924030088/0001437749-24-030088-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595248/000143774924030088/gnpx20240920_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T01:33:32.420982+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}